Similar articles for PMID: 19668880

Year	Number of Results
1951	1
1952	1
1953	2
1954	4
1955	1
1956	1
1957	5
1958	5
1961	1
1962	5
1963	2
1965	1
1969	2
1972	1
1976	1
1977	1
1978	1
1980	3
1981	3
1982	1
1984	1
1988	2
1997	1
1998	1
1999	1
2001	1
2002	3
2003	4
2004	7
2005	7
2006	16
2007	16
2008	38
2009	63
2010	8
2011	2
2012	1
2013	2
2014	1
2015	1
2016	1
2017	1
2019	2
2020	1
2022	0

1

Variation of M3 muscarinic receptor expression in different prostate tissues and its significance.

Song W, Yuan M, Zhao S. Song W, et al. Saudi Med J. 2009 Aug;30(8):1010-6. Saudi Med J. 2009. PMID: 19668880

2

Muscarinic receptors and their mRNAs in type 2 Goto-Kakizaki diabetic rat prostate.

Saito M, Kazuyama E, Shimizu S, Dimitriadis F, Kinoshita Y, Masuda E, Yamada S, Satoh K. Saito M, et al. Prostate. 2010 Oct 1;70(14):1533-9. doi: 10.1002/pros.21188. Prostate. 2010. PMID: 20687226

3

[Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].

Zeng R, Liu ZY, Sun YH, Xu CL, Gao X, Jiao L. Zeng R, et al. Zhonghua Nan Ke Xue. 2010 Nov;16(11):967-72. Zhonghua Nan Ke Xue. 2010. PMID: 21218636 Chinese.

4

[The specific expression profile of homeobox gene NKX3.1 mRNA and protein in prostate tissues and its relationship with primary prostate cancer].

Yang GS, Wang YM, Chen ZD. Yang GS, et al. Zhonghua Nan Ke Xue. 2006 Feb;12(2):137-40, 144. Zhonghua Nan Ke Xue. 2006. PMID: 16519150 Chinese.

5

[Expressions of telomerase reverse transcriptase and vascular endothelial growth factor and their correlation in prostate cancer].

Li X, Wang N, Zhang Y, Zhang SX, Lin Q, Tang J. Li X, et al. Zhonghua Nan Ke Xue. 2005 Oct;11(10):724-6, 730. Zhonghua Nan Ke Xue. 2005. PMID: 16281501 Clinical Trial. Chinese.

6

[Expression of cyclooxygenase-2 and vascular endothelial growth factor in human prostate cancer and its significance].

Jin TX, Li XG, Wu WY, Piao DM, Feng JY, Sang J. Jin TX, et al. Zhonghua Nan Ke Xue. 2006 Mar;12(3):207-10. Zhonghua Nan Ke Xue. 2006. PMID: 16597032 Chinese.

7

Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.

Mariani S, Salvatori L, Basciani S, Arizzi M, Franco G, Petrangeli E, Spera G, Gnessi L. Mariani S, et al. J Urol. 2006 Jun;175(6):2072-7; discussion 2077. doi: 10.1016/S0022-5347(06)00273-4. J Urol. 2006. PMID: 16697805

8

Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.

Tang J, Wang Z, Li X, Li J, Shi H. Tang J, et al. Artif Cells Blood Substit Immobil Biotechnol. 2008;36(2):83-93. doi: 10.1080/10731190801932074. Artif Cells Blood Substit Immobil Biotechnol. 2008. PMID: 18437586

9

M2, M3, and M4 muscarinic receptors are expressed in the guinea pig gallbladder.

Cabadak H, Cuadra AE, El-Fakahany EE, Kan B. Cabadak H, et al. J Recept Signal Transduct Res. 2009;29(1):63-6. doi: 10.1080/10799890802687416. J Recept Signal Transduct Res. 2009. PMID: 19519171

10

Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.

Mansfield KJ, Liu L, Moore KH, Vaux KJ, Millard RJ, Burcher E. Mansfield KJ, et al. BJU Int. 2007 Jun;99(6):1433-8. doi: 10.1111/j.1464-410X.2007.06866.x. BJU Int. 2007. PMID: 17428242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed